Therapeutic activity of two xanthones in a xenograft murine model of human chronic lymphocytic leukemia - Wikidata - wikimedia - TriplyDB

Therapeutic activity of two xanthones in a xenograft murine model of human chronic lymphocytic leukemia

Therapeutic activity of two xanthones in a xenograft murine model of human chronic lymphocytic leukemia

http://www.wikidata.org/entity/Q34467890

about

Isolation of Bioactive Rotenoids and Isoflavonoids from the Fruits of Millettia caerulea Design of novel BH3 mimetics for the treatment of chronic lymphocytic leukemia.Apoptosis inducers in chronic lymphocytic leukemia.

P2860

Q37116016-560F5F7B-8EA3-4EBA-8469-F3689078560C Q37997623-EBB87E97-9C74-423C-89E7-C1E374E7B8FA Q38187815-F8EEC5C2-1929-4D40-A0C3-2F5F8CB90F51

P2860

Therapeutic activity of two xanthones in a xenograft murine model of human chronic lymphocytic leukemia

http://www.wikidata.org/entity/Q34467890

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Therapeutic activity of two xa ...... n chronic lymphocytic leukemia

@ast

Therapeutic activity of two xa ...... n chronic lymphocytic leukemia

@en

Therapeutic activity of two xa ...... n chronic lymphocytic leukemia

@nl

type

label

Therapeutic activity of two xa ...... n chronic lymphocytic leukemia

@ast

Therapeutic activity of two xa ...... n chronic lymphocytic leukemia

@en

Therapeutic activity of two xa ...... n chronic lymphocytic leukemia

@nl

prefLabel

Therapeutic activity of two xa ...... n chronic lymphocytic leukemia

@ast

Therapeutic activity of two xa ...... n chronic lymphocytic leukemia

@en

Therapeutic activity of two xa ...... n chronic lymphocytic leukemia

@nl

P1433

Q34467890-AF9BAA7F-5595-4559-ADF4-2C8EB16E6FCF

P1476

Q34467890-1A90C80A-7C5A-4331-A5CF-E87ECE7E48C0

P2093

Q34467890-2771ECEC-00B9-4DCF-92FF-A215DAAB606C

Q34467890-53A5E75A-E2EA-4E29-B9F4-A63862EAFDFA

Q34467890-7E0F70B2-E222-4C79-A26B-AC31663F82A8

Q34467890-99068E20-3489-4020-856F-8C3F36DE968D

Q34467890-9FE2FD1E-AD4D-4C35-81C2-40DE4672ADB5

Q34467890-F26BF31C-5C55-44FE-ADB4-DD38CF10C53C

P2860

Q34467890-07B5472F-2992-4451-9A15-F2E270D98D45

Q34467890-1A458E80-75AC-4C8A-AA3D-A17D1D49D4AC

Q34467890-25B97BFE-B090-41B3-B71F-2207D7A427F9

Q34467890-2BB51558-9ADE-4B34-9615-ECD922030274

Q34467890-3577396E-2C0D-4CA6-B4A6-5A0033BFD68F

Q34467890-649D39D6-A1B4-4204-96AD-D33261B93A23

Q34467890-90288536-62F9-407F-8412-B61D986E8431

Q34467890-ADB2BB29-26B7-4D23-969F-CC1153807C5C

Q34467890-B67A3510-1F11-40D7-A794-5F06B6654724

P2888

Q34467890-2CD70F1B-9885-48E6-883B-5F036AE85059

P304

Q34467890-C4480EBD-6873-4C86-B598-58B31288020A

P31

Q34467890-F8CAC130-1404-4B34-BAC6-7B3420851CF6

P356

Q34467890-BF054417-C352-4BBB-9DC4-C4FEA868CCA0

P478

Q34467890-C5CD9FDF-F6AE-48D6-A902-1809CCF9D812

P50

Q34467890-5121040C-DE3B-4A11-A1A4-FA6BDCA738F1

P577

Q34467890-B9834D5E-D54C-4F3F-A8A8-DBF6047E3FED

P5875

Q34467890-95F28542-5EF2-4082-9780-71951B54CA35

P6179

Q34467890-09355414-A415-4540-B393-78669B769F49

P698

Q34467890-1898867D-E9C8-413D-B041-5A51A2ACA5E2

P921

Q34467890-18D5B2C2-5DB3-4DF3-8D08-8B46F36929B0

Q34467890-72513D74-A277-4A83-986F-785944E46EBA

Q34467890-7FD022B9-8178-4FCC-9366-1143550CF0EC

Q34467890-9827C756-D787-4CC4-8519-FED65F7E4BB8

P932

Q34467890-FC5460E4-FE1E-4085-8F10-85C82CACA525

P356

P1433

Journal of Hematology & Oncology

P1476

Therapeutic activity of two xa ...... n chronic lymphocytic leukemia

@en

P2093

Christian Berthou

http://www.w3.org/2001/XMLSchema#string

Christian Billard

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Kolb

http://www.w3.org/2001/XMLSchema#string

Karine Le Ster

http://www.w3.org/2001/XMLSchema#string

Michèle Meyer

http://www.w3.org/2001/XMLSchema#string

Séverine Loisel

http://www.w3.org/2001/XMLSchema#string

P2860

Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression

Re-establishment of a normal apoptotic process as a therapeutic approach in B-CLL.

Update in the management of chronic lymphocytic leukemia.

Molecular and cellular mechanisms of CLL: novel therapeutic approaches.

Establishment of a novel human B-CLL-like xenograft model in nude mouse.

A human B-cell CLL model established by transplantation of JOK-1 cells into SCID mice and an anti-leukemia efficacy of fludarabine phosphate.

Role of B-cell antigen receptor-associated molecules and lipid rafts in CD5-induced apoptosis of B CLL cells.

Cytotoxic xanthones from Cudrania tricuspidata.

Apoptotic effects on B-cell chronic lymphocytic leukemia (B-CLL) cells of heterocyclic compounds isolated from Guttiferaes.

P2888

P304

49

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1756-8722-3-49

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-12-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49664890

http://www.w3.org/2001/XMLSchema#string

P6179

1020720665

http://www.w3.org/2001/XMLSchema#string

P698

21138552

http://www.w3.org/2001/XMLSchema#string

P921

allanxanthone C

P932

3016254

http://www.w3.org/2001/XMLSchema#string